DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Global Precision Medicine Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Precision Medicine market is expected to reach $144.4 billion by 2026, growing at a CAGR of 14.5% from 2018 to 2026.

Some of the factors such as increasing the acceptance rate of gene therapies in developed economies and growing advancements in cancer biology are fuelling market growth. However, high cost of the development and increasing price of genetic testing, is restraining the market growth.

Based on the technology, companion diagnostics segment has witnessed significant growth. Companion diagnostics help healthcare experts to assess the advantages and side-effects or risk of therapeutic products on a patient.

The key vendors mentioned are Teva Pharmaceutical Industries, Tepnel Pharma Services, Quest Diagnostics Incorporated, Qiagen, Pfizer, Novartis, Nanostring Technologies, Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics, and Biocrates Life Sciences.

Key Questions Answered in the Report

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics3.1 Drivers3.2 Restraints

4 Market Environment

5 Global Precision Medicine Market, By Product5.1 Introduction5.2 Services5.3 Instruments5.4 Consumables

6 Global Precision Medicine Market, By Technology6.1 Introduction6.2 Targeted Therapeutics6.3 Molecular Diagnostics6.4 Gene Sequencing6.5 Drug Discovery6.6 Companion Diagnostics6.7 Bioinformatics6.8 Big Data Analytics6.9 Pharmacogenomics (PGX)6.10 Other Technologies

7 Global Precision Medicine Market, By Therapeutics7.1 Introduction7.2 Genetic Tests7.3 Direct to Consumer Tests7.4 Immunology7.5 Gastroenterology7.6 Neurology/Physiatry7.7 Infectious Diseases7.8 Central Nervous System (CNS)7.9 Cardiovascular Disease (CVD)7.10 Cancer/Oncology7.11 Skin Diseases7.12 Respiratory Diseases7.13 Renal Disease7.14 Pulmonary Disease7.15 Ophthalmology7.16 Metabolic Disease7.17 Hematology

8 Global Precision Medicine Market, By End-user8.1 Introduction8.2 Pharmaceutical Companies8.3 Medical Devices8.4 Hospitals8.5 Home Care8.6 Diagnostic Companies8.7 Biotechnology Companies8.8 Healthcare-IT/Big Data firms8.9 Clinical Laboratories

9 Global Precision Medicine Market, By Geography9.1 Introduction9.2 North America9.3 Europe9.4 Asia-Pacific9.5 South America9.6 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape11.1 Teva Pharmaceutical Industries Ltd.11.2 Tepnel Pharma Services11.3 Quest Diagnostics Incorporated11.4 Qiagen N.V.11.5 Pfizer Inc.11.6 Novartis AG11.7 Nanostring Technologies11.8 Medtronic11.9 Laboratory Corporation of America Holdings11.10 Intomics11.11 Hoffmann-La Roche11.12 Ferrer inCode11.13 Eagle Genomics Ltd.11.14 Biocrates Life Sciences AG

For more information about this report visit https://www.researchandmarkets.com/r/i41sk8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the rest here:
Global Precision Medicine Market Review 2016-2019 and Forecast to 2026, Featuring Financials of Key Players - PRNewswire